Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
ItalyA study of PM54 and pembrolizumab in adults with advanced cancer
ItalyA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
ItalyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
ItalyA study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations
ItalyA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
ItalyA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
ItalyA study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B
ItalyA study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia
ItalyA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
ItalyA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
ItalyA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
